Inicio › Enfermedad pulmonar intersticial › Nueva York › New York City
Ensayos clínicos de Enfermedad pulmonar intersticial en New York City, NY
18 estudios para Enfermedad pulmonar intersticial buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
ReclutandoFase 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
ReclutandoFase 3
- Weill Cornell Medicine-New York-60569, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoFase 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoFase 3
- USA005, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
ReclutandoFase 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
ReclutandoFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
ReclutandoFase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
ReclutandoFase 2
- Icahn School of Medicine at Mount Sinai, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Reclutando
- Weill Cornell University Medical College, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
ReclutandoFase 3
- NYU Langone Health, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoEstudio observacional
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
ReclutandoEstudio observacional
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
ReclutandoFase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutandoFase 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
ReclutandoEstudio observacional
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
ReclutandoFase 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
ReclutandoFase 2
- aTyr Investigative Site, New York
Más información sobre Enfermedad pulmonar intersticial en MedlinePlus
Ensayos de Enfermedad pulmonar intersticial en otras ciudades
- Philadelphia, PA16 estudios
- Los Angeles, CA14 estudios
- Charleston, SC13 estudios
- Kansas City, KS13 estudios
- Durham, NC13 estudios
- Chicago, IL12 estudios
- Houston, TX12 estudios
- Aurora, CO11 estudios
- Ann Arbor, MI11 estudios
- Salt Lake City, UT9 estudios
- Dallas, TX9 estudios
- Boston, MA9 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.